ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Destiny Pharma Plc

Destiny Pharma Plc (DEST)

3.00
0.00
(0.00%)
Cerrado 22 Enero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
3.00
Postura de Compra
2.50
Postura de Venta
3.50
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
2.25 Rango de 52 semanas 74.50
Precio Anterior
3.00
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen promedio (3 m)
0.00
Volumen financiero
-
Precio Promedio Ponderado
-

DEST Últimas noticias

AIM Cancellation - Destiny Pharma plc

AIM 13 August 2024   NOTICE   13/08/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the company the following securities have been cancelled from...

Destiny Pharma PLC Last Day of Dealings on AIM

Destiny Pharma PLC 12 August 2024   Destiny Pharma plc ("Destiny Pharma" or "the Company")  Last Day of Dealings on AIM Brighton, United Kingdom - 12 August 2024 - Destiny Pharma plc (AIM:...

Destiny Pharma PLC Director/PDMR Shareholding

Destiny Pharma PLC 05 August 2024   Destiny Pharma plc ("Destiny Pharma" or "the Company")  Director/PDMR Shareholding Brighton, United Kingdom - 5 August 2024 - Destiny Pharma plc (AIM:...

Destiny Pharma shares fall amid XF-73 fending off MRSA in wounds

Destiny Pharma PLC on Monday announced positive data for its lead drug exeporfinium chloride, known as XF-73, and to ...

Destiny Pharma PLC Result of GM and Cancellation of Trading on AIM

Destiny Pharma PLC 31 July 2024   Destiny Pharma plc ("Destiny Pharma" or "the Company")   Result of General Meeting and Cancellation of Admission to Trading on AIM     Brighton, United...

Destiny Pharma looks to go private to raise funds, avoid liquidation

Destiny Pharma PLC on Monday proposed going private to pursue funding opportunities after failing to secure a licensi ...

Destiny Pharma PLC Proposed Cancellation of Admission to Trading

Destiny Pharma PLC 15 July 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED...

Destiny Pharma PLC Exercise of Options and Total Voting Rights

Destiny Pharma PLC 20 June 2024   20 June 2024 Destiny Pharma plc ("Destiny Pharma" or the "Company")   Exercise of Options and Total Voting Rights   Brighton, United Kingdom - 20 June 2024 ...

IN BRIEF: Destiny Pharma presents "exciting" data for ringworm drug

C - biotechnology company, focused on developing and commercialising medicines for life-threatening infections - Annou ...

Destiny Pharma PLC Efficacy of XF-70 in Fungal Skin Infections

Destiny Pharma PLC 18 June 2024   Destiny Pharma plc ("Destiny Pharma" or "the Company")   Efficacy of XF-70 Demonstrated: A Potential New Agent for the Treatment of Fungal Skin Infections  ...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10033300DE
40033300DE
120033300DE
26-2-4057.752.252949553.34713705DE
52-71.5-95.973154362474.574.52.2543336314.90538286DE
156-96-96.9696969697991012.2530087631.16011639DE
260-41-93.1818181818442462.2520632639.11735348DE

DEST - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Destiny Pharma?
El precio actual de las acciones de Destiny Pharma es 3.00p
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Destiny Pharma?
Destiny Pharma ha negociado en un rango de 2.25p a 74.50p durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M
weedtrader420 weedtrader420 4 minutos hace
BITCOIN XRP AIMAW Aqualung💦Cross eyed Mary $120,000 TARGET ✊😮‍💨☝️
BTCUSD
Saving Grace Saving Grace 6 minutos hace
Yes, when NDA's are removed, it's boom time. Everyone at the plant is excited and ready.

https://businessjournaldaily.com/wp-content/uploads/2024/10/Foxconn-Model-C-EV.jpg

https://i.vimeocdn.com/video/1780032285-1eadf9821975b71cc554aa3a7d443a4b59265d9b3a16081b2573d7c443
NRDE
ThoroughBread ThoroughBread 8 minutos hace
SFIO .0028 sleeper.
SFIO
glens0 glens0 9 minutos hace
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 11 minutos hace
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 11 minutos hace
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 12 minutos hace
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 13 minutos hace
KPIFF
wadegarret wadegarret 13 minutos hace
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 13 minutos hace
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 14 minutos hace
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 16 minutos hace
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 16 minutos hace
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 16 minutos hace
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 17 minutos hace
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 18 minutos hace
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 19 minutos hace
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 19 minutos hace
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 20 minutos hace
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 21 minutos hace
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 21 minutos hace
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 24 minutos hace
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 24 minutos hace
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL

Su Consulta Reciente

Delayed Upgrade Clock